These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 11994058
1. The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine. Yasuda SU, Zannikos P, Young AE, Fried KM, Wainer IW, Woosley RL. Br J Clin Pharmacol; 2002 May; 53(5):519-25. PubMed ID: 11994058 [Abstract] [Full Text] [Related]
3. Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans. Eap CB, Lessard E, Baumann P, Brawand-Amey M, Yessine MA, O'Hara G, Turgeon J. Pharmacogenetics; 2003 Jan; 13(1):39-47. PubMed ID: 12544511 [Abstract] [Full Text] [Related]
4. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol. Bramer SL, Suri A. Clin Pharmacokinet; 1999 Jan; 37 Suppl 2():41-51. PubMed ID: 10702886 [Abstract] [Full Text] [Related]
5. Stereoselective pharmacokinetics of chlorpheniramine and the effect of ranitidine. Koch KM, O'Connor-Semmes RL, Davis IM, Yin Y. J Pharm Sci; 1998 Sep; 87(9):1097-100. PubMed ID: 9724561 [Abstract] [Full Text] [Related]
7. Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans. Lessard E, Yessine MA, Hamelin BA, O'Hara G, LeBlanc J, Turgeon J. Pharmacogenetics; 1999 Aug; 9(4):435-43. PubMed ID: 10780263 [Abstract] [Full Text] [Related]
8. Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans. Abolfathi Z, Fiset C, Gilbert M, Moerike K, Bélanger PM, Turgeon J. J Pharmacol Exp Ther; 1993 Sep; 266(3):1196-201. PubMed ID: 8371133 [Abstract] [Full Text] [Related]
9. Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes. Dalén P, Dahl M, Andersson K, Bertilsson L. Br J Clin Pharmacol; 2000 Feb; 49(2):180-4. PubMed ID: 10671914 [Abstract] [Full Text] [Related]
10. Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Nicholson AN, Pascoe PA, Turner C, Ganellin CR, Greengrass PM, Casy AF, Mercer AD. Br J Pharmacol; 1991 Sep; 104(1):270-6. PubMed ID: 1686208 [Abstract] [Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses. Kuroda T, Nagata S, Takizawa Y, Tamura N, Kusano K, Mizobe F, Hariu K. Vet J; 2013 Aug; 197(2):433-7. PubMed ID: 23489843 [Abstract] [Full Text] [Related]
12. Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexiline. Davies BJ, Herbert MK, Coller JK, Somogyi AA, Milne RW, Sallustio BC. Br J Clin Pharmacol; 2008 Mar; 65(3):347-54. PubMed ID: 17875193 [Abstract] [Full Text] [Related]
13. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates. Lemma GL, Wang Z, Hamman MA, Zaheer NA, Gorski JC, Hall SD. Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446 [Abstract] [Full Text] [Related]
14. Stereospecific versus nonstereospecific assessments for the bioequivalence of two formulations of racemic chlorpheniramine. Bui TH, Fernandez C, Vu K, Nguyen KH, Thuillier A, Farinotti R, Arnaud P, Gimenez F. Chirality; 2000 Aug; 12(8):599-605. PubMed ID: 10897096 [Abstract] [Full Text] [Related]
15. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans. Capon DA, Bochner F, Kerry N, Mikus G, Danz C, Somogyi AA. Clin Pharmacol Ther; 1996 Sep; 60(3):295-307. PubMed ID: 8841152 [Abstract] [Full Text] [Related]
16. Metoprolol metabolism via cytochrome P4502D6 in ethnic populations. Johnson JA, Burlew BS. Drug Metab Dispos; 1996 Mar; 24(3):350-5. PubMed ID: 8820427 [Abstract] [Full Text] [Related]
17. Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia. Inglis SC, Herbert MK, Davies BJ, Coller JK, James HM, Horowitz JD, Morris RG, Milne RW, Somogyi AA, Sallustio BC. Pharmacogenet Genomics; 2007 May; 17(5):305-12. PubMed ID: 17429312 [Abstract] [Full Text] [Related]
18. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity. Hamelin BA, Bouayad A, Méthot J, Jobin J, Desgagnés P, Poirier P, Allaire J, Dumesnil J, Turgeon J. Clin Pharmacol Ther; 2000 May; 67(5):466-77. PubMed ID: 10824625 [Abstract] [Full Text] [Related]
19. The antitussive effect of dextromethorphan in relation to CYP2D6 activity. Abdul Manap R, Wright CE, Gregory A, Rostami-Hodjegan A, Meller ST, Kelm GR, Lennard MS, Tucker GT, Morice AH. Br J Clin Pharmacol; 1999 Sep; 48(3):382-7. PubMed ID: 10510150 [Abstract] [Full Text] [Related]
20. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of chlorpheniramine and diphenhydramine in rabbits. Simons KJ, Chen X, Fraser TG, Simons FE. Pharm Res; 1996 Feb; 13(2):301-4. PubMed ID: 8932453 [Abstract] [Full Text] [Related] Page: [Next] [New Search]